Arq Bras Endocrinol Metab vol.50 número4

It was hypothesized that the simvastatin inhibits the relapse of tooth movement in rats, through inhibition of bone resorption (and the increase in bone formation)

female rats by measuring biochemical parameters including the levels of bone-resorbing cytokines (interleukin-1 and interleukin-6), a bone formation marker (osteocalcin) and a

We evaluated the following data in all 37 patients: S-HCy, markers of bone formation: total S-ALP and serum osteocal- cin (S-OC), marker of bone resorption serum Crosslaps, serum

Essential thrombocythemia is an acquired myeloproliferative disorder characterized by the proliferation of megakaryocytes in bone marrow, leading to a persistent increase in the

The use of autogenous cancellous bone grafting in areas of incomplete ossification has been proposed in order to optimize bone formation and remodeling by

Osteoporosis is a metabolic disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and

Bisphosphonate therapy normalizes bone turnover, reduces the number of bone remodeling sites and stress risers, restores the balance of bone remodeling, prevents bone loss

Bone forming surface and bone- formation rate were reduced signiicantly by 58% and 80%, respectively, in the hypoparathyroid subjects, and remodeling activation frequency in